RA Capital Management, L.P. 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:43 pm Sale |
2024-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 7,777,942 8.900% |
-682,148 (-8.06%) |
Filing |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 8,460,090 9.990% |
956,114 (+12.74%) |
Filing |
| 2024-02-14 5:01 pm Sale |
2023-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 7,503,976 9.990% |
-188,014 (-2.44%) |
Filing |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 7,691,990 9.990% |
-41,086,182 (-84.23%) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 48,778,172 9.990% |
7,235,168 (+17.42%) |
Filing |
| 2021-02-16 4:34 pm Purchase |
2020-12-31 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 41,543,004 9.990% |
41,543,004 (New Position) |
Filing |